Comparative biology and pathology of oxidative stress in Alzheimer and other neurodegenerative diseases: Beyond damage and response

Comparative Biochemistry and Physiology - C Toxicology and Pharmacology

Volumn 133, Issue 4, 2002, Pages 507-513

  Perry, George ^a   Taddeo, Marta A ^a   Nunomura, Akihiko ^b   Zhu, Xiongwei ^a   Zenteno Savin, Tania ^c   Drew, Kelly L ^d   Shimohama, Shun ^e   Avila, Jesús ^f   Castellani, Rudolph J ^a   Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c Playa Palo Santa Rita ^*  (Mexico)

^d UNIVERSITY OF ALASKA FAIRBANKS   (United States)

^e KYOTO UNIVERSITY   (Japan)

^f CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

Author keywords

Aging; Alzheimer disease; Hibernation; Homeostasis; Iron; Mitochondria; Neurodegenerative disease; Oxidative damage; Reactive oxygen species

Indexed keywords

ADAPTATION; AGING; ALZHEIMER DISEASE; CELL DAMAGE; CELL SURVIVAL; CELL VIABILITY; COMPARATIVE STUDY; CONFERENCE PAPER; DEATH; DEGENERATIVE DISEASE; HEAD INJURY; HIBERNATION; HOMEOSTASIS; HUMAN; NERVE FUNCTION; OXIDATIVE STRESS; PATHOLOGY; PRIORITY JOURNAL; STROKE;

EID: 6444244258     PISSN: 15320456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1532-0456(02)00119-9     Document Type: Conference Paper

References (39)

1. Aliev G., Smith M.A., Seyidova D., et al. The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease. Brain Pathol. 12:2002;21-35.
2. Gems D., Partridge L. Insulin/IGF signalling and aging: seeing the bigger picture. Curr. Opin. Genet. Dev. 11:2001;287-292.
3. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., Binder L.I. Abnormal phosphorylation of the microtubule-associated protein τ (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. USA. 83:1986;4913-4917.
4. Guarente L., Kenyon C. Genetic pathways that regulate aging in model organisms. Nature. 408:2000;255-262.
5. +-ATPase activities in Alzheimer's disease brains. Neurosci. Lett. 254:1998;141-144.
6. Heininger, K., 2000. A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events. Rev. Neurosci. 11 Spec No.: 213-328.
7. Hirai K., Aliev G., Nunomura A., et al. Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 21:2001;3017-3023.
8. Kalaria R.N., Gravina S.A., Schmidley J.W., Perry G., Harik S.I. The glucose transporter of the human brain and blood-brain barrier. Ann. Neurol. 24:1988;757-764.
9. Kenyon C. A conserved regulatory system for aging. Cell. 105:2001;165-168.
10. Marx J. New leads on the 'how' of Alzheimer's. Science. 293:2001;2192-2194.
11. Mourelatos Z., Gonatas N.K., Stieber A., Gurney M.E., Dal Canto M.C. The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu, Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease. Proc. Nat. Acad. Sci. USA. 93:1996;5472-5477.
12. Nunomura A., Perry G., Pappolla M.A., et al. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J. Neurosci. 19:1999;1959-1964.
13. Nunomura A., Perry G., Aliev G., et al. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60:2001;759-767.
14. Odetti P., Garibaldi S., Norese R., et al. Lipoperoxidation is selectively involved in progressive supranuclear palsy. J. Neuropathol. Exp. Neurol. 59:2000;393-397.
15. Perez M., Valpuesta J.M., de Garcini E.M., et al. Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy. Am. J. Pathol. 152:1998;1531-1539.
16. Perez M., Cuadros R., Smith M.A., Perry G., Avila J. Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4-hydroxy-2-nonenal. FEBS Lett. 486:2000;270-274.
17. Pérez M., Hernández F., Gómez A., Smith M.A., Perry G., Avila J. Formation of aberrant phosphotau fibrillar polymers in neural cultured cells. Eur. J. Biochem. 269:2002;1484-1489.
18. Perry G., Rizzuto N., Autilio-Gambetti L., Gambetti P. Paired helical filaments from Alzheimer disease patients contain cytoskeletal components. Proc. Natl. Acad. Sci. USA. 82:1985;3916-3920.
19. Perry G., Nunomura A., Smith M.A. A suicide note from Alzheimer disease neurons? (News and Views). Nature Med. 4:1998a;897-898.
20. Perry G., Nunomura A., Lucassen P., Lassmann H., Smith M.A. Apoptosis and Alzheimer's disease (Letter). Science. 282:1998b;1268-1269.
21. Perry G., Castellani R.J., Hirai K., Smith M.A. Reactive oxygen species mediate cellular damage in Alzheimer disease. J. Alzheimer's Disease. 1:1998c;45-55.
22. Perry G., Roder H., Nunomura A., et al. Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. Neuroreport. 10:1999;2411-2415.
23. Perry G., Zhu X., Smith M.A. Do neurons have a choice in death? Am. J. Pathol. 158:2001;1-2.
24. Russell R.L., Siedlak S.L., Raina A.K., Bautista J.M., Smith M.A., Perry G. Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease. Arch. Biochem. Biophys. 370:1999;236-239.
25. Sayre L.M., Perry G., Harris P.L.R., Liu Y., Schubert K.A., Smith M.A. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J. Neurochem. 74:2000;270-279.
26. Small G.W., Komo S., La Rue A., et al. Early detection of Alzheimer's disease by combining apolipoprotein E and neuroimaging. Ann. NY Acad. Sci. 802:1996;70-78.
27. Sternberger N.H., Sternberger L.A., Ulrich J. Aberrant neurofilament phosphorylation in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 82:1985;4274-4276.
28. Stieber A., Mourelatos Z., Gonatas N.K. In Alzheimer's disease the Golgi apparatus of a population of neurons without neurofibrillary tangles is fragmented and atrophic. Am. J. Pathol. 148:1996;415-426.
29. Takeda A., Smith M.A., Avilá J., et al. In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of τ induced by 4-hydroxy-2-nonenal modification. J. Neurochem. 75:2000a;1234-1241.
30. Takeda A., Perry G., Abraham N.G., et al. Overexpression of heme oxygenase in neuronal cells, the possible interaction with tau. J. Biol. Chem. 275:2000b;5395-5399.
31. Terry R.D. The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. J. Neuropath. Exp. Neurol. 55:1996;10231025.
32. United States General Accounting Office's Report to the Secretary of Health and Human Services (1998) Alzheimer's Disease: Estimates of prevalence in the United States. GAO/HEHS-98-16.
33. Wataya T., Nunomura A., Smith M.A., et al. High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal. J. Biol. Chem. 277:2002;4644-4648.
34. Zhang J., Perry G., Smith M.A., et al. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am. J. Pathol. 154:1999;1423-1429.
35. Zhou F., Zhu X., Castellani R.J., et al. Hibernation, a model of neuroprotection. Am. J. Pathol. 158:2001;2145-2151.
36. Zhu X., Rottkamp C.A., Boux H., Takeda A., Perry G., Smith M.A. Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease. J. Neuropathol. Exp. Neurol. 59:2000;880-888.
37. Zhu X., Raina A.K., Rottkamp C.A., et al. Activation and redistribution of c-Jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J. Neurochem. 76:2001a;435-441.
38. Zhu X., Castellani R.J., Takeda A., et al. Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis. Mech. Aging Dev. 123:2001b;39-46.
39. Zhu X., Rottkamp C.A., Hartzler A., et al. Activation of MKK6, an upstream activator of p38, in Alzheimer's disease. J. Neurochem. 79:2001c;311-318.